kidney failure

High magnification micrograph of diffuse proliferative lupus nephritis
Pharma

Novartis presses pause on Fabhalta lupus nephritis trial

Amid a steady advance of kidney-focused label expansions, Novartis’ Fabhalta is slowing its roll in a key potential autoimmune niche.
Fraiser Kansteiner Oct 19, 2026 10:13am
Bayer

Bayer tees up Kerendia for major CKD label expansion

Mar 16, 2026 9:46am
Broken glass

Glass-breaking fears force Exela to recall 49 injectable batches

Oct 14, 2022 2:23pm
NBA All-Star and transplant recipient Sean Elliot teams with Fresenius on National Kidney Month campaign

Fresenius nets NBA All-Star Elliott for CKD awareness campaign

Mar 9, 2022 7:55am
Alan and Aisha

DaVita and Kidney Foundation spur living donors—and patient asks

Jun 23, 2021 8:25am